<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hamsyl® &#8211; Gennova Bio</title>
	<atom:link href="https://gennova.bio/category/product-publications/hamsyl/feed/" rel="self" type="application/rss+xml" />
	<link>https://gennova.bio</link>
	<description>Transforming Healthcare</description>
	<lastBuildDate>Mon, 04 Nov 2024 10:27:54 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://gennova.bio/wp-content/uploads/2020/01/cropped-Gennova-fav-icon-32x32.png</url>
	<title>Hamsyl® &#8211; Gennova Bio</title>
	<link>https://gennova.bio</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India</title>
		<link>https://gennova.bio/randomized-parallel-group-open-label-bioequivalence-trial-of-intramuscular-pegaspargase-in-patients-with-relapsed-acute-lymphoblastic-leukemia-2-2/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 04 Nov 2024 10:26:13 +0000</pubDate>
				<category><![CDATA[Hamsyl®]]></category>
		<category><![CDATA[Product Publications]]></category>
		<guid isPermaLink="false">http://gennova.bio/?p=12712</guid>

					<description><![CDATA[South Asian J Cancer, 2023 Apr 10;12(4):371-377. doi: 10.1055/s-0042-1759785 https://pubmed.ncbi.nlm.nih.gov/38130281/]]></description>
										<content:encoded><![CDATA[<p style="font-weight: 400;">South Asian J Cancer, 2023 Apr 10;12(4):371-377.<br />
<span style="font-weight: 400;">doi: 10.1055/s-0042-1759785</span></p>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/38130281/">https://pubmed.ncbi.nlm.nih.gov/38130281/</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Systematic clinical and pharmacological monitoring of a PEG-asparaginase biogeneric (HAMSYL®) in paediatric patients with newly-diagnosed acute lymphoblastic leukaemia</title>
		<link>https://gennova.bio/randomized-parallel-group-open-label-bioequivalence-trial-of-intramuscular-pegaspargase-in-patients-with-relapsed-acute-lymphoblastic-leukemia-2/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 04 Nov 2024 10:22:33 +0000</pubDate>
				<category><![CDATA[Hamsyl®]]></category>
		<category><![CDATA[Product Publications]]></category>
		<guid isPermaLink="false">http://gennova.bio/?p=12709</guid>

					<description><![CDATA[Pediatr Hematol Oncol. 2023; 8(4):S48. doi: 10.1016/j.phoj.2023.10.122 https://www.sciencedirect.com/science/article/pii/S2468124523001821?via%3Dihub]]></description>
										<content:encoded><![CDATA[<p style="font-weight: 400;">Pediatr Hematol Oncol. 2023; 8(4):S48. doi: 10.1016/j.phoj.2023.10.122</p>
<p><a href="https://www.sciencedirect.com/science/article/pii/S2468124523001821?via%3Dihub">https://www.sciencedirect.com/science/article/pii/S2468124523001821?via%3Dihub</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia</title>
		<link>https://gennova.bio/randomized-parallel-group-open-label-bioequivalence-trial-of-intramuscular-pegaspargase-in-patients-with-relapsed-acute-lymphoblastic-leukemia/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 20 Jul 2020 11:33:14 +0000</pubDate>
				<category><![CDATA[Hamsyl®]]></category>
		<category><![CDATA[Product Publications]]></category>
		<guid isPermaLink="false">http://gennova.bio/?p=11183</guid>

					<description><![CDATA[JCO Glob Oncol. 2020 Jul;6:1009-1016. doi: 10.1200/GO.20.00113. https://pubmed.ncbi.nlm.nih.gov/32628582/]]></description>
										<content:encoded><![CDATA[<p><em>JCO Glob Oncol. 2020 Jul;6:1009-1016. doi: 10.1200/GO.20.00113.</em></p>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/32628582/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32628582/</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India</title>
		<link>https://gennova.bio/retrospective-post-marketing-study-on-the-use-of-bio-similar-pegasparagase-among-acute-lymphoblastic-leukemia-patients-in-india/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 09 Apr 2020 19:21:03 +0000</pubDate>
				<category><![CDATA[Hamsyl®]]></category>
		<category><![CDATA[Product Publications]]></category>
		<guid isPermaLink="false">http://localhost/gennova/?p=10562</guid>

					<description><![CDATA[Pediatric Hematology Oncology Journal, Volume 3, Issue 1, March 2018, Pages 9-12 https://www.sciencedirect.com/science/article/pii/S2468124517301031]]></description>
										<content:encoded><![CDATA[<p><em>Pediatric Hematology Oncology Journal, Volume 3, Issue 1, March 2018, Pages 9-12</em></p>
<p><em><a href="https://www.sciencedirect.com/science/article/pii/S2468124517301031" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/S2468124517301031</a></em></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity.</title>
		<link>https://gennova.bio/experience-with-generic-pegylated-l-asparaginase-in-children-with-acute-lymphoblastic-leukemia-and-monitoring-of-serum-asparaginase-activity/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 09 Apr 2020 19:19:29 +0000</pubDate>
				<category><![CDATA[Hamsyl®]]></category>
		<category><![CDATA[Product Publications]]></category>
		<guid isPermaLink="false">http://localhost/gennova/?p=10560</guid>

					<description><![CDATA[Pediatr Hematol Oncol. 2018 Aug – Sep;35(5-6):331-340. doi: 10.1080/08880018.2018.1538277 https://www.ncbi.nlm.nih.gov/pubmed/30488741]]></description>
										<content:encoded><![CDATA[<p><em><sup>Pediatr Hematol Oncol. 2018 Aug – Sep;35(5-6):331-340. doi: 10.1080/08880018.2018.1538277</sup></em></p>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/30488741" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pubmed/30488741</a></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
